The Inhibitory Effect of Ticlopidine on VEGF Induced Corneal Neovascularization
Journal of the Korean Ophthalmological Society
;
: 1392-1396, 2003.
Artigo
em Coreano
| WPRIM
| ID: wpr-209862
ABSTRACT
PURPOSE:
Ticlopidine, which has platelet inhibitory property, is currently used in peripheral arterial obstructive disease, ischemic stroke, and coronary artery disease. It is also known to have antiangiogenesis effect. We studied the effect of ticlopidine on rabbit corneal angiogenesis induced by VEGF.METHODS:
In control group, a hydron pellet containing 300ng VEGF and phosphate buffered saline(PBS) was implanted intrastromally in the superior cornea. In treatment group, a hydron pellet containing 300ng VEGF and 375micro gram ticlopidine was implanted as the same manner. At 3, 5, and 7 day after implantation, we examined corneas under the microscope and estimated the angiogenesis score.RESULTS:
At 5 and 7 day after implantation, ticlopidine-treated group had mean angiogenesis score of 27.9 and 49.1(p=0.014, independent t-test), while control group scored 13.0 and 25.3(p=0.004).CONCLUSIONS:
In a rabbit corneal pocket assay, ticlopidine appears to have inhibitory effect on VEGF-induced corneal angiogenesis.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Arteriopatias Oclusivas
/
Plaquetas
/
Doença da Artéria Coronariana
/
Ticlopidina
/
Neovascularização da Córnea
/
Córnea
/
Acidente Vascular Cerebral
/
Inibidores da Angiogênese
/
Fator A de Crescimento do Endotélio Vascular
Idioma:
Coreano
Revista:
Journal of the Korean Ophthalmological Society
Ano de publicação:
2003
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS